These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 368977)

  • 21. Pathogenesis of Escherichia coli cystitis and pyelonephritis: apparent lack of significance of bacterial motility and chemotaxis towards human urine.
    Herrmann B; Burman LG
    Infection; 1985; 13(1):4-7. PubMed ID: 3886554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.
    Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS
    Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis.
    Mobley HL; Island MD; Massad G
    Kidney Int Suppl; 1994 Nov; 47():S129-36. PubMed ID: 7869662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevation in anti-Proteus antibodies in patients with rheumatoid arthritis from Bermuda and England.
    Subair H; Tiwana H; Fielder M; Binder A; Cunningham K; Ebringer A; Wilson C; Hudson MJ
    J Rheumatol; 1995 Oct; 22(10):1825-8. PubMed ID: 8991977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection.
    Bahrani FK; Johnson DE; Robbins D; Mobley HL
    Infect Immun; 1991 Oct; 59(10):3574-80. PubMed ID: 1680106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transurethral instillation with fusion protein MrpH.FimH induces protective innate immune responses against uropathogenic Escherichia coli and Proteus mirabilis.
    Habibi M; Asadi Karam MR; Bouzari S
    APMIS; 2016 Jun; 124(6):444-52. PubMed ID: 26918627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immobilizing antibodies in urine. II. Prevention of ascending spread of Proteus mirabilis.
    Pazin GJ; Braude AI
    Invest Urol; 1974 Sep; 12(2):129-33. PubMed ID: 4604561
    [No Abstract]   [Full Text] [Related]  

  • 28. Complications of maternal spina bifida.
    Powell B; Garvey M
    Ir J Med Sci; 1984 Jan; 153(1):20-1. PubMed ID: 6365834
    [No Abstract]   [Full Text] [Related]  

  • 29. EXPERIMENTAL PYELONEPHRITIS IN THE MOUSE PRODUCED BY ESCHERICHIA COLI, PSEUDOMONAS AERUGINOSA AND PROTEUS MIRABILIS.
    GORRILL RH; DENAVASQUEZ SJ
    J Pathol Bacteriol; 1964 Jan; 87():79-87. PubMed ID: 14106358
    [No Abstract]   [Full Text] [Related]  

  • 30. Bacterial adherence in the human ileal conduit: a morphological and bacteriological study.
    Bruce AW; Reid G; Chan RC; Costerton JW
    J Urol; 1984 Jul; 132(1):184-8. PubMed ID: 6726953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathogenic characteristics of Escherichia coli strains in cases of asymptomatic bacteriuria and symptomatic urinary tract infections].
    Misiewicz IA; Galiński J
    Med Dosw Mikrobiol; 1989; 41(3-4):151-9. PubMed ID: 2701235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis.
    Habibi M; Asadi Karam MR; Shokrgozar MA; Oloomi M; Jafari A; Bouzari S
    Mol Immunol; 2015 Apr; 64(2):285-94. PubMed ID: 25562574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decrease in anti-Proteus mirabilis but not anti-Escherichia coli antibody levels in rheumatoid arthritis patients treated with fasting and a one year vegetarian diet.
    Kjeldsen-Kragh J; Rashid T; Dybwad A; Sioud M; Haugen M; Førre O; Ebringer A
    Ann Rheum Dis; 1995 Mar; 54(3):221-4. PubMed ID: 7748020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An experimental model for ascending acute pyelonephritis caused by Escherichia coli or proteus in rats.
    Larsson P; Kaijser B; Baltzer IM; Olling S
    J Clin Pathol; 1980 Apr; 33(4):408-12. PubMed ID: 6995491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteriuria following extracorporeal shock wave lithotripsy of infection stones.
    Michaels EK; Fowler JE; Mariano M
    J Urol; 1988 Aug; 140(2):254-6. PubMed ID: 3294439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Urinary and serum o-antibodies in patients with chronic pyelonephritis (author's transl)].
    Budde E; Naumann G; Nimmich W; Handschuck I
    Zentralbl Bakteriol Orig A; 1977 Sep; 239(1):104-12. PubMed ID: 339606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregnancy following urinary diversion.
    Barrett RJ; Peters WA
    Obstet Gynecol; 1983 Nov; 62(5):582-6. PubMed ID: 6621946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of urinary tract infections with SolcoUrovac].
    Litschgi M
    Geburtshilfe Frauenheilkd; 1987 Feb; 47(2):107-10. PubMed ID: 3106132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Providencia stuartii: a common cause of antibiotic-resistant bacteriuria in patients with long-term indwelling catheters.
    Warren JW
    Rev Infect Dis; 1986; 8(1):61-7. PubMed ID: 3081988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antireflux ureteroileal anastomoses: two experimental technique.
    Starr A; Rose DH; Cooper JF; Snyder RN
    Invest Urol; 1974 Nov; 12(3):165-71. PubMed ID: 4613686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.